A Case Report of Monkeypox in an Adult Patient from Italy: Clinical and Dermoscopic Manifestations, Diagnosis and Management.
Monkeypox
Orthopoxvirus
dermatologic symptoms
dermoscopy
epidemy
vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
10 Nov 2022
10 Nov 2022
Historique:
received:
30
09
2022
revised:
27
10
2022
accepted:
07
11
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Monkeypox infection is an emerging problem and a new challenge for modern medicine. With an increasing number of new cases worldwide, new data regarding the clinical manifestations, characteristics of the patients, risk factors and treatment options are coming to light. Knowing more about the disease will allow to elaborate new helpful methods to facilitate its diagnosis. Special attention should be paid to the careful dermatologic and dermoscopic examination of the patient. The analysis of available data also suggests possible strategies for the prevention of Monkeypox virus spread; the vaccine against Smallpox seems to be an effective solution. This case report describes the diagnostic approach and management of a non-vaccinated adult patient with several risk factors and a history of sexually transmitted disease. The patient had no history of travel abroad. Even though a clinical diagnose of Monkeypox can be challenging due to its similarities with skin rashes caused by other Orthopoxviral infections, there are fine differences between the rashes which can be helpful in their differentiation, although laboratory analysis is required for a definitive identification. A careful study of the characteristics of the rash, such as diameter, its presence on palms and soles and its evolution in time, provided important clues for the diagnosis of Monkeypox infection. The lack of vaccinations in the history of the patient was another crucial finding in the diagnostic process.
Identifiants
pubmed: 36366410
pii: vaccines10111903
doi: 10.3390/vaccines10111903
pmc: PMC9694441
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
N Engl J Med. 2018 Jul 5;379(1):44-53
pubmed: 29972742
Australas J Dermatol. 2021 Feb;62(1):27-36
pubmed: 32895964
J Virol. 2013 Jan;87(2):900-11
pubmed: 23135728
Lancet Infect Dis. 2004 Jan;4(1):15-25
pubmed: 14720564
PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141
pubmed: 35148313
J Virol. 2004 May;78(9):4433-43
pubmed: 15078924
Lancet Infect Dis. 2022 Aug;22(8):1153-1162
pubmed: 35623380
Euro Surveill. 2022 Jun;27(22):
pubmed: 35656836
Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043
pubmed: 30981594
New Microbiol. 2018 Apr;41(2):95-105
pubmed: 29498740
Br J Dermatol. 2022 Nov;187(5):822-823
pubmed: 35822390
Indian J Dermatol. 2021 Jul-Aug;66(4):445
pubmed: 34759418
J Am Acad Dermatol. 2022 Nov;87(5):e171-e174
pubmed: 35753551
Acta Trop. 1988 Dec;45(4):297-307
pubmed: 2907258
Sci Rep. 2021 Jun 22;11(1):13085
pubmed: 34158533